Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Jason Sloane MD

Jason Sloane MD

Endocrinologist, Slocum Dickson Medical Group, Utica, New York

Jason Sloane, MD, is a practicing endocrinologist in Upstate NY where he moved to be closer to family. He recently completed his endocrinology fellowship at Massachusetts General Hospital. He earned his medical degree from Duke University School of Medicine and completed his internal medicine residency at Albany Medical College where he was Chief Resident. His areas of interest include diabetes specifically in the areas of continuous glucose monitoring technology, hybrid closed loop insulin pumps, diabetes outreach through support groups, and celiac disease. He is also interested in osteoporosis and menopause treatment. He is currently working at a private practice as an endocrinologist but he will be continuing his research with celiac disease and type 1 diabetes in the near future. He will also be continuing his efforts with diabetes support groups.

Recent Contributions to PracticeUpdate:

  1. ADA 2018: SGLT2 Inhibitors in the Management of Type 2 Diabetes
  2. ADA 2018: Inpatient Diabetes Management Guidelines—Use of the Insulin Pump and CGM
  3. ADA 2018: Intensive Glycemic Control During Pregnancy
  4. ADA 2018: The Future of Islet Cell Transplant
  5. ADA 2018: Sequencing Injectable Therapies in Type 2 Diabetes
  6. ADA 2018: An Overview of Injectable Therapies in the Management of Type 2 Diabetes

Most Read This Week

Recently Updated